Palasis Maria

Track

Insider profile

Palasis Maria's trades of Lyra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
29.96
Quantity 500 -5.6%
Value US$14,982
Transaction date
Planned sale
Price
29.33
Quantity 906 -9.2%
Value US$26,570
Transaction date
Planned sale
Price
27.45
Quantity 119 -1.2%
Value US$3,267
Transaction date
Planned sale
Price
26.86
Quantity 1,287 -11.4%
Value US$34,567
Transaction date
Proposed sale
Price
26.78
Quantity 2,812
Value US$75,305
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-27 2026-01-27
PrS Proposed sale
64,805
161.90
US$3,504,814 		64,805 161.90 US$3,504,814
2026-01-08 2026-01-06
PlS Planned sale
13,753 -5.1%
66.17
US$29,831 		13,753 -5.1% 66.17 US$29,831
2026-01-06 2026-01-06
PrS Proposed sale
72,713
499.93
US$3,028,913 		72,713 499.93 US$3,028,913
2025-12-02 2025-12-01
PlS Planned sale
500 -5.6%
29.96
US$14,982 		500 -5.6% 29.96 US$14,982
2025-12-02 2025-12-01
PlS Planned sale
906 -9.2%
29.33
US$26,570 		906 -9.2% 29.33 US$26,570
2025-11-05 2025-10-31
PlS Planned sale
119 -1.2%
27.45
US$3,267 		119 -1.2% 27.45 US$3,267
2025-11-05 2025-10-31
PlS Planned sale
1,287 -11.4%
26.86
US$34,567 		1,287 -11.4% 26.86 US$34,567
2025-10-31 2025-10-31
PrS Proposed sale
2,812
26.78
US$75,305 		2,812 26.78 US$75,305
2025-10-14 2025-10-14
PrS Proposed sale
537
7.23
US$3,881 		537 7.23 US$3,881
2025-07-14 2025-07-10
PlS Planned sale
1,565 -0.1%
8.91
US$13,944 		1,565 -0.1% 8.91 US$13,944
2025-07-10 2025-07-10
PrS Proposed sale
1,565
8.91
US$13,945 		1,565 8.91 US$13,945
2025-04-09 2025-04-09
PrS Proposed sale
39,567
0.09
US$3,545 		39,567 0.09 US$3,545